Journal of the Korea Academia-Industrial cooperation Society (한국산학기술학회논문지)

The Korea Academia-Industrial cooperation Society (한국산학기술학회)
권호 표지
DOI QR코드

DOI QR Code

A Study on the R&D Trend and Patent Analysis of Treatments for Degenerative Brain Diseases

퇴행성 뇌질환 치료제의 연구개발 및 특허동향 분석

  • Sohn, Eun-Soo (Korea Institute of Science and Technology Information) ;
  • Sohn, Eun-Hwa (Department of Herbal Medicine Resource, Kangwon National University)
  • 손은수 (한국과학기술정보연구원) ;
  • 손은화 (강원대학교 생약자원개발학과)
  • Received : 2011.08.22
  • Accepted : 2011.10.06
  • Published : 2011.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Degenerative brain diseases including Alzheimer's diseases, Parkinson's diseases increase in frequency with age. They are amongst the most costly and devastating diseases to patients and their families. Therefore developing therapies for degenerative brain diseases is of the highest priority. Recently therapeutics for these diseases have undergone scrutiny by many clinical trials according to the advances of cellular and molecular neurobiology. This review is focused on studies investigating the current therapeutic strategies already undergone different stage of clinical trials and recent R&D trend by nations through patent analysis on treatments for degegerative brain diseases.

현대사회가 급속히 고령화됨에 따라 알츠하이머질환, 파킨슨병 등 퇴행성 뇌질환의 발생속도도 급증하고 있다. 퇴행성 뇌질환 대부분은 아직도 근원적인 치료가 불가능한 채 발병원인도 명확하지 않은 상태이나 최근 세포분자학적 기술 수준의 향상으로 퇴행성 뇌질환의 원인 규명 및 치료제 개발에 활기를 띠고 있다. 본 연구에서는 퇴행성 뇌질환 기작별 최근 치료제의 연구개발 동향과 국내외 기술동향을 조사 분석 하였으며, 과학계량학적 특허정보 분석을 통해 국가별 기술수준을 파악하고 기술개발 전망을 제시하였다.

Keywords

References

  1. S. K. Sonkusare et al., "Dementia of Alzheimer's disease and other neurodegenerative disorders-memantine, a new hope", Pharmacological Research, 51(1), pp.1-17, 2005. https://doi.org/10.1016/j.phrs.2004.05.005
  2. P. Stanzione and D. Tropepi. "Drugs and clinical trials in neurodegenerative diseases", Ann Ist Super Sanita, 47(1), pp.49-54, 2011.
  3. Alan L. Porter and Scott W. Tech Mining: Exploiting New Technologies for Competitive Advantage, Cunningham, Hoboken, NJ, John Wiley & Sons, 33-40. 2005.
  4. Z. Griliches, Patent statistics as economic indicators: A survey, Journal of economic literature, 18, pp.1661-1707, 1990.
  5. Halperin I, Morelli M, Korczyn AD, Youdim MB, Mandel SA., "Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases", Neurotherapeutics. 6(1), pp.128-140, 2009. https://doi.org/10.1016/j.nurt.2008.10.033
  6. J.B. Standridge, "Pharmacotherapeutic approaches to the treatment of Alzheimer's disease", Clin. Ther., 26(5), pp.615-630, 2004. https://doi.org/10.1016/S0149-2918(04)90064-1
  7. Carreiras MC, Marco JL, "Recent approaches to novel anti-Alzheimer therapy", Curr Pharm Des., 10(25), pp.3167-3175, 2004. https://doi.org/10.2174/1381612043383421
  8. Collins S, Sigtermans MJ, Dahan A, Zuurmond WW, Perez RS., "NMDA receptor antagonists for the treatment of neuropathic pain", Pain Med. 11(11), pp.1726-1742, 2010. https://doi.org/10.1111/j.1526-4637.2010.00981.x
  9. Alan H Nagahara1, David A Merrill1 et al., "Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease" Nature Medicine 15, pp.331-337, 2009. https://doi.org/10.1038/nm.1912
  10. A. Rocchi, S. Pellegrini, G. Siciliano and L. Murri, "Causative and susceptibility genes for Alzheimer's disease: a review", Brain Res. Bull., 61(1), pp.1-24, 2003. https://doi.org/10.1016/S0361-9230(03)00067-4
  11. Kerchner GA, Boxer AL., "Bapineuzumab", Expert Opin Biol Ther. 10(7), pp.1121-1130, 2010. https://doi.org/10.1517/14712598.2010.493872
  12. L. Aron and R. Klein, "Repairing the parkinsonian brain with neurotrophic factors", Trends Neurosci. 34(2), pp.88-100, 2011. https://doi.org/10.1016/j.tins.2010.11.001
  13. L. Y. Fan and M. J. Chiu, "Pharmacological treatment for Alzheimer's disease: current approaches and future strategies", Acta Neurol Taiwan. 19(4), pp.228-245, 2010.
  14. Simmons DA, Rex CS, Palmer L, Pandyarajan V, Fedulov V, Gall CM, Lynch G., "Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice", Proc Natl Acad Sci USA. 24;106(12), pp.4906-4911, 2009. https://doi.org/10.1073/pnas.0811228106
  15. Lim ST, Airavaara M, Harvey BK., "Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS", Pharmacol Res. 61(1), pp.14-26, 2010. https://doi.org/10.1016/j.phrs.2009.10.002
  16. Wu YP, Chen WS, Teng C, Zhang N., "Stem cells for the treatment of neurodegenerative diseases", Molecules 15; pp.6743-6758, 2010. https://doi.org/10.3390/molecules15106743